1. Home
  2. Labeler Index
  3. Gilead Sciences, Inc.
  4. 61958-2002
  5. NDC Package Code: 61958-2002-2 Descovy

NDC Package 61958-2002-2 Descovy

Emtricitabine And Tenofovir Alafenamide Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
61958-2002-2
Package Description:
30 TABLET in 1 BLISTER PACK
Product Code:
61958-2002
Proprietary Name:
Descovy
Non-Proprietary Name:
Emtricitabine And Tenofovir Alafenamide
Substance Name:
Emtricitabine; Tenofovir Alafenamide Fumarate
Usage Information:
This product is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. This product is also approved in the US to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. Also, it will not always prevent HIV infection. To help prevent becoming infected with HIV and to decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.
11-Digit NDC Billing Format:
61958200202
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1747691 - emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet
  • RxCUI: 1747697 - Descovy 200 MG / 25 MG Oral Tablet
  • RxCUI: 1747697 - emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Descovy]
  • RxCUI: 1747697 - Descovy (emtricitabine 200 MG / tenofovir alafenamide 25 MG) Oral Tablet
  • RxCUI: 2590641 - emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Gilead Sciences, Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • EMTRICITABINE 200 mg/1
  • TENOFOVIR ALAFENAMIDE FUMARATE 25 mg/1
    • Pharmacologic Class(es):
  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Nucleoside Reverse Transcriptase Inhibitors - [MoA] (Mechanism of Action)
  • Nucleosides - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA208215
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    04-04-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    61958-2002-130 TABLET in 1 BOTTLE, PLASTIC

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 61958-2002-2?

    The NDC Packaged Code 61958-2002-2 is assigned to a package of 30 tablet in 1 blister pack of Descovy, a human prescription drug labeled by Gilead Sciences, Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 61958-2002 included in the NDC Directory?

    Yes, Descovy with product code 61958-2002 is active and included in the NDC Directory. The product was first marketed by Gilead Sciences, Inc. on April 04, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 61958-2002-2?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 61958-2002-2?

    The 11-digit format is 61958200202. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-161958-2002-25-4-261958-2002-02